OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001841330

Pasithea Therapeutics Corp. (KTTA)

Pasithea Therapeutics Corp. (CIK 0001841330, ticker KTTA, EIN 85-1591963) reported revenue of $486,559 for FY2022 (2022-01-01 to 2022-12-31) and net income of -$20.43 million (-$20,427,683) for FY2025 (2025-01-01 to 2025-12-31), as filed in its 10-K filed 2023-03-30 (accession 0001213900-23-024755) and its 10-K filed 2026-03-30 (accession 0001213900-26-036434).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001841330
TickersKTTA (Nasdaq)
EIN85-1591963
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer category<br>Emerging growth company
Entity typeoperating
Olympus entity IDorg_7fnjnz1zssezp6sn13tr886fa0
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$486,559FY20222022-01-01 to 2022-12-3110-K2023-03-300001213900-23-024755Revenues
Net income-$20,427,683FY20252025-01-01 to 2025-12-3110-K2026-03-300001213900-26-036434NetIncomeLoss
Total assets$60,240,070FY2025as of 2025-12-3110-K2026-03-300001213900-26-036434Assets
Total liabilities$5,020,832FY2025as of 2025-12-3110-K2026-03-300001213900-26-036434Liabilities
Stockholders' equity$55,219,238FY2025as of 2025-12-3110-K2026-03-300001213900-26-036434StockholdersEquity
Operating cash flow-$15,211,490FY20252025-01-01 to 2025-12-3110-K2026-03-300001213900-26-036434NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$2.91 per shareFY20252025-01-01 to 2025-12-3110-K2026-03-300001213900-26-036434EarningsPerShareDiluted
Shares outstanding24,939,948 sharesFY2025as of 2026-03-2410-K2026-03-300001213900-26-036434EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20222022-01-01 to 2022-12-31$486,55910-K2023-03-300001213900-23-024755
RevenueFY20212021-01-01 to 2021-12-31$15,06210-K2023-03-300001213900-23-024755
Net incomeFY20252025-01-01 to 2025-12-31-$20,427,68310-K2026-03-300001213900-26-036434
Net incomeFY20242024-01-01 to 2024-12-31-$13,904,58410-K2026-03-300001213900-26-036434
Net incomeFY20232023-01-01 to 2023-12-31-$15,961,65810-K2025-03-240001013762-25-001646
Net incomeFY20222022-01-01 to 2022-12-31-$13,936,45210-K2024-03-290001213900-24-027508
Net incomeFY20212021-01-01 to 2021-12-31-$2,173,52110-K2023-03-300001213900-23-024755

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-08-142026-06-300001213900-26-090146ea0300974-10q_pasithea.htm
10-Q2026-05-152026-03-310001213900-26-057837ea0289157-10q_pasithea.htm
10-K2026-03-302025-12-310001213900-26-036434ea0275535-10k_pasithea.htm
10-Q2025-11-132025-09-300001213900-25-110093ea0264188-10q_pasithea.htm
10-Q2025-08-142025-06-300001213900-25-076557ea0250837-10q_pasithea.htm
10-Q2025-05-152025-03-310001213900-25-044281ea0240596-10q_pasithea.htm
10-K2025-03-242024-12-310001013762-25-001646ea0230888-10k_pasithea.htm
10-Q2024-11-132024-09-300001213900-24-097496ea0219124-10q_pasithea.htm
10-Q2024-08-132024-06-300001213900-24-068297ea0210146-10q_pasithea.htm
10-Q2024-05-142024-03-310001213900-24-042981ea0205253-10q_pasithea.htm
10-K2024-03-292023-12-310001213900-24-027508ea0200415-10k_pasithea.htm
10-Q2023-11-132023-09-300001213900-23-086198f10q0923_pasithea.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001841330published by the sourcedata.sec.gov/submissions/CIK0001841330.json2026-10-21
Employer Identification Number (EIN) · US-EIN85-1591963published by the sourcedata.sec.gov/submissions/CIK0001841330.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001841330.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001841330.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001841330" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001841330/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001841330/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1841330"}

On SEC EDGAR

About this data